| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.27B | 6.27B | 6.22B | 6.34B | 6.50B | 7.52B |
| Gross Profit | 3.21B | 3.22B | 3.10B | 3.01B | 3.07B | 3.95B |
| EBITDA | 747.04M | 860.30M | 601.23M | 610.95M | 346.77M | 1.27B |
| Net Income | 234.67M | 234.67M | 116.37M | 45.72M | -158.75M | 548.35M |
Balance Sheet | ||||||
| Total Assets | 5.65B | 5.65B | 5.64B | 5.85B | 6.81B | 7.28B |
| Cash, Cash Equivalents and Short-Term Investments | 1.27B | 1.27B | 794.45M | 555.29M | 621.86M | 970.52M |
| Total Debt | 563.65M | 563.65M | 558.85M | 660.87M | 677.59M | 335.74M |
| Total Liabilities | 2.47B | 2.47B | 2.52B | 2.75B | 3.24B | 3.32B |
| Stockholders Equity | 3.08B | 3.08B | 3.00B | 2.98B | 3.26B | 3.62B |
Cash Flow | ||||||
| Free Cash Flow | 734.33M | 734.33M | 644.25M | 314.88M | -285.12M | 609.90M |
| Operating Cash Flow | 859.02M | 859.02M | 790.54M | 502.36M | 124.39M | 1.26B |
| Investing Cash Flow | 31.80M | 65.89M | -294.29M | -189.16M | -400.26M | -636.70M |
| Financing Cash Flow | -276.30M | -298.24M | -403.49M | -366.25M | -84.83M | -552.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | HK$8.83B | -28.18 | -4.66% | 1.77% | -2.15% | -202.71% | |
67 Neutral | HK$7.22B | 34.76 | 5.55% | 1.41% | 7.29% | -33.19% | |
66 Neutral | HK$12.76B | 15.94 | 16.58% | 5.89% | 1.10% | -7.88% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | HK$15.21B | 41.13 | 5.56% | 2.52% | ― | ― | |
58 Neutral | HK$6.65B | 28.68 | 7.63% | 2.21% | -3.39% | 91.63% | |
58 Neutral | HK$7.38B | 11.32 | 6.29% | ― | 100.45% | 2.89% |
Vitasoy International Holdings Limited has announced an interim ordinary dividend of HKD 0.04 per share for the six months ending September 30, 2025. The dividend will be paid on December 23, 2025, with the ex-dividend date set for December 9, 2025. This announcement reflects the company’s ongoing financial performance and commitment to returning value to shareholders, potentially impacting its market position and investor relations positively.
The most recent analyst rating on (HK:0345) stock is a Hold with a HK$7.00 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.
Vitasoy International Holdings reported a 6% decrease in revenue for the six months ending September 30, 2025, primarily due to challenges in the Chinese Mainland market. Despite this, the company maintained a stable gross profit margin and saw a slight increase in profit attributable to equity shareholders. The company experienced varying performance across its regional operations, with strong growth in Australia and New Zealand, and momentum in Singapore’s tofu business, while facing temporary setbacks in Hong Kong and Macau. The company also repurchased shares and declared an interim dividend, reflecting confidence in its financial position.
The most recent analyst rating on (HK:0345) stock is a Hold with a HK$7.00 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.
Vitasoy International Holdings Limited has announced that its Board of Directors will convene on November 25, 2025, to review and approve the interim financial results for the six months ending September 30, 2025. The meeting will also consider the declaration of an interim dividend, if applicable. This announcement is significant as it may impact the company’s financial strategy and shareholder returns, reflecting its operational performance and market positioning.
The most recent analyst rating on (HK:0345) stock is a Hold with a HK$8.50 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.